(Circulation. 1996;93:800-809.)
© 1996 American Heart Association, Inc.
Articles |
Differential Cardiac Effects of Growth Hormone and Insulin-like Growth Factor1 in the Rat
A Combined In Vivo and In Vitro Evaluation
Presented in part at the 67th Scientific Session, American Heart Association, Dallas, Tex, November 14-17, 1994, and published in abstract form (Circulation. 1994;90[suppl I]:I-17).
From the Charles A. Dana Research Institute and the Harvard-Thorndike Laboratory, Department of Medicine (Cardiovascular Division [A.C., H.S., S.E.K., J.P.M., P.S.D.] and Endocrinology [A.C.M.]), Beth Israel Hospital and Harvard Medical School, Boston, Mass; and Genentech Inc (R.C.), South San Francisco, Calif.
Correspondence to Pamela S. Douglas, MD, Cardiovascular Division, Beth Israel Hospital, 330 Brookline Ave, Boston, MA 02215. E-mail pdouglas@bih.harvard.edu.
Background Despite their increasing clinical use and recent evidence that growth hormone (GH) and insulin-like growth factor–1 (IGF-1) target the heart, there has been no systematic investigation of the effects of GH and IGF-1 on the cardiovascular system.
Methods and Results Sixty normal but growing adult female rats were randomized to receive 4 weeks of treatment with GH (3.5 mg · kg-1 · d-1), IGF-1 (3 mg · kg-1 · d-1), a combination of the two, or placebo. Transthoracic echocardiograms were performed at baseline and at 2 weeks and 4 weeks of treatment. After the final echocardiography, rats underwent either closed-chest left ventricular (LV) catheterization or Langendorff perfusion studies. Myocyte diameter and interstitial tissue fraction were assessed by morphometric histology. Echocardiographic and ex vivo data demonstrated a LV hypertrophic response in all three groups of treated animals that was most marked in the GH group, which alone exhibited a concentric growth pattern (relative wall thickness, 0.52 versus 0.42 to 0.44 in the other groups; P<.001). At 4 weeks, cardiac index was significantly higher and total systemic vascular resistance was lower in all groups of treated animals than in control animals (both P<.001), whereas arterial blood pressure did not differ significantly. All indexes of in vivo and in vitro cardiac function were higher in GH- and IGF-1–treated rats than in control animals, whereas combination therapy yielded a blunted effect. Myocyte diameter was increased in all three treated groups without an increase in interstitial tissue.
Conclusions Exogenous administration of GH and IGF-1 in the normal adult rat induces a cardiac hypertrophic response without development of significant fibrosis. Cardiac performance is increased both in vivo and in the isolated heart.
Key Words: growth factors • ventricular hypertrophy • cardiac function
This article has been cited by other articles:
 |
|
 |
|
  A. Cittadini, L. Saldamarco, A. M. Marra, M. Arcopinto, G. Carlomagno, M. Imbriaco, D. Del Forno, C. Vigorito, B. Merola, U. Oliviero, et al. Growth Hormone Deficiency in Patients with Chronic Heart Failure and Beneficial Effects of Its Correction J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3329 - 3336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wang, J. Deng, W. Tian, B. Xiang, T. Yang, G. Li, J. Wang, M. Gruwel, T. Kashour, J. Rendell, et al. Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts Am J Physiol Heart Circ Physiol, September 1, 2009; 297(3): H1020 - H1031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. J. Rider, J. M. Francis, M. K. Ali, S. E. Petersen, M. Robinson, M. D. Robson, J. P. Byrne, K. Clarke, and S. Neubauer Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J. Am. Coll. Cardiol., August 18, 2009; 54(8): 718 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gnecchi, Z. Zhang, A. Ni, and V. J. Dzau Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy Circ. Res., November 21, 2008; 103(11): 1204 - 1219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Haider, S. Jiang, N. M. Idris, and M. Ashraf IGF-1-Overexpressing Mesenchymal Stem Cells Accelerate Bone Marrow Stem Cell Mobilization via Paracrine Activation of SDF-1{alpha}/CXCR4 Signaling to Promote Myocardial Repair Circ. Res., November 21, 2008; 103(11): 1300 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bruel, T. E.H. Christoffersen, and J. R. Nyengaard Growth hormone increases the proliferation of existing cardiac myocytes and the total number of cardiac myocytes in the rat heart Cardiovasc Res, December 1, 2007; 76(3): 400 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Egecioglu, I. J. Andersson, E. Bollano, V. Palsdottir, B. G. Gabrielsson, J. J. Kopchick, O. Skott, P. Bie, J. Isgaard, M. Bohlooly-Y, et al. Growth hormone receptor deficiency in mice results in reduced systolic blood pressure and plasma renin, increased aortic eNOS expression, and altered cardiovascular structure and function Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1418 - E1425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Pantos, I. Mourouzis, C. Xinaris, A. D Kokkinos, K. Markakis, A. Dimopoulos, M. Panagiotou, T. Saranteas, G. Kostopanagiotou, and D. V Cokkinos Time-dependent changes in the expression of thyroid hormone receptor {alpha}1 in the myocardium after acute myocardial infarction: possible implications in cardiac remodelling Eur. J. Endocrinol., April 1, 2007; 156(4): 415 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Marzullo, C. Marcassa, R. Campini, E. Eleuteri, A. Minocci, A. Sartorio, R. Vettor, A. Liuzzi, and G. Grugni Conditional Cardiovascular Response to Growth Hormone Therapy in Adult Patients with Prader-Willi Syndrome J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1364 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gnecchi, H. He, N. Noiseux, O. D. Liang, L. Zhang, F. Morello, H. Mu, L. G. Melo, R. E. Pratt, J. S. Ingwall, et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement FASEB J, April 1, 2006; 20(6): 661 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Salerno, V. Esposito, V. Farina, G. Radetti, A. Umbaldo, D. Capalbo, L. Spinelli, S. Muzzica, G. Lombardi, and A. Colao Improvement of Cardiac Performance and Cardiovascular Risk Factors in Children with GH Deficiency after Two Years of GH Replacement Therapy: An Observational, Open, Prospective, Case-Control Study J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1288 - 1295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nagaya, K. Kangawa, T. Itoh, T. Iwase, S. Murakami, Y. Miyahara, T. Fujii, M. Uematsu, H. Ohgushi, M. Yamagishi, et al. Transplantation of Mesenchymal Stem Cells Improves Cardiac Function in a Rat Model of Dilated Cardiomyopathy Circulation, August 23, 2005; 112(8): 1128 - 1135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Dong, L. B. Esberg, Z. K. Roughead, J. Ren, and J. T. Saari Increased contractility of cardiomyocytes from copper-deficient rats is associated with upregulation of cardiac IGF-I receptor Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H78 - H84. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tivesten, A. Barlind, K. Caidahl, N. Klintland, A. Cittadini, C. Ohlsson, and J. Isgaard Growth hormone-induced blood pressure decrease is associated with increased mRNA levels of the vascular smooth muscle KATP channel J. Endocrinol., October 1, 2004; 183(1): 195 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Iemitsu, T. Miyauchi, S. Maeda, T. Tanabe, M. Takanashi, M. Matsuda, and I. Yamaguchi Exercise training improves cardiac function-related gene levels through thyroid hormone receptor signaling in aged rats Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1696 - H1705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ibarra, M. Estrada, L. Carrasco, M. Chiong, J. L. Liberona, C. Cardenas, G. Diaz-Araya, E. Jaimovich, and S. Lavandero Insulin-like Growth Factor-1 Induces an Inositol 1,4,5-Trisphosphate-dependent Increase in Nuclear and Cytosolic Calcium in Cultured Rat Cardiac Myocytes J. Biol. Chem., February 27, 2004; 279(9): 7554 - 7565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Colao, D. Ferone, P. Marzullo, and G. Lombardi Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management Endocr. Rev., February 1, 2004; 25(1): 102 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Clayton Cardiovascular Function in Acromegaly Endocr. Rev., June 1, 2003; 24(3): 272 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cittadini, L. Ines Comi, S. Longobardi, V. Rocco Petretta, C. Casaburi, L. Passamano, B. Merola, E. Durante-Mangoni, L. Sacca, and L. Politano A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies Eur. Heart J., April 1, 2003; 24(7): 664 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. L. Norby, L. E. Wold, J. Duan, K. K. Hintz, and J. Ren IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E658 - E666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Colao, L. Spinelli, A. Cuocolo, S. Spiezia, R. Pivonello, C. di Somma, D. Bonaduce, M. Salvatore, and G. Lombardi Cardiovascular Consequences of Early-Onset Growth Hormone Excess J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3097 - 3104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-P. Tsai, J.-M. Yu, Y.-L. Wu, C.-Y. Huang, and F.-L. Chen Change of serum growth factors in infants with isolated ventricular defect undergoing surgical repair Ann. Thorac. Surg., June 1, 2002; 73(6): 1765 - 1768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Welch, D. Plank, S. Witt, B. Glascock, E. Schaefer, S. Chimenti, A. M. Andreoli, F. Limana, A. Leri, J. Kajstura, et al. Cardiac-Specific IGF-1 Expression Attenuates Dilated Cardiomyopathy in Tropomodulin-Overexpressing Transgenic Mice Circ. Res., April 5, 2002; 90(6): 641 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cittadini, A. Berggren, S. Longobardi, C. Ehrnborg, R. Napoli, T. Rosen, S. Fazio, K. Caidahl, B.-A. Bengtsson, and L. Sacca Supraphysiological Doses of GH Induce Rapid Changes in Cardiac Morphology and Function J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1654 - 1659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Khan, D. C. Sane, T. Wannenburg, and W. E. Sonntag Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system Cardiovasc Res, April 1, 2002; 54(1): 25 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nagaya, K. Miyatake, M. Uematsu, H. Oya, W. Shimizu, H. Hosoda, M. Kojima, N. Nakanishi, H. Mori, and K. Kangawa Hemodynamic, Renal, and Hormonal Effects of Ghrelin Infusion in Patients with Chronic Heart Failure J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5854 - 5859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Galderisi, G. Vitale, G. Lupoli, M. Barbieri, G. Varricchio, C. Carella, O. de Divitiis, and G. Paolisso Inverse Association Between Free Insulin-Like Growth Factor-1 and Isovolumic Relaxation in Arterial Systemic Hypertension Hypertension, October 1, 2001; 38(4): 840 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nagaya, M. Uematsu, M. Kojima, Y. Ikeda, F. Yoshihara, W. Shimizu, H. Hosoda, Y. Hirota, H. Ishida, H. Mori, et al. Chronic Administration of Ghrelin Improves Left Ventricular Dysfunction and Attenuates Development of Cardiac Cachexia in Rats With Heart Failure Circulation, September 18, 2001; 104(12): 1430 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Gutstein, G. E. Morley, D. Vaidya, F. Liu, F. L. Chen, H. Stuhlmann, and G. I. Fishman Heterogeneous Expression of Gap Junction Channels in the Heart Leads to Conduction Defects and Ventricular Dysfunction Circulation, September 4, 2001; 104(10): 1194 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bohlooly-Y, L. Carlson, B. Olsson, H. Gustafsson, I. J. L. Andersson, J. Tornell, and G. Bergstrom Vascular Function and Blood Pressure in GH Transgenic Mice Endocrinology, August 1, 2001; 142(8): 3317 - 3323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Khan, C. D. Lynch, D. C. Sane, M. C. Willingham, and W. E. Sonntag Growth Hormone Increases Regional Coronary Blood Flow and Capillary Density in Aged Rats J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2001; 56(8): B364 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Ogilvy-Stuart, M. A. Soos, S. J. Hands, M. Y. Anthony, D. B. Dunger, and S. O'Rahilly Hypoglycemia and Resistance to Ketoacidosis in a Subject without Functional Insulin Receptors J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3319 - 3326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Palmen, M.J.A.P. Daemen, R. Bronsaer, W.R.M. Dassen, H.R. Zandbergen, M. Kockx, J.F.M. Smits, R. van der Zee, and P.A. Doevendans Cardiac remodeling after myocardial infarction is impaired in IGF-1 deficient mice Cardiovasc Res, June 1, 2001; 50(3): 516 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Gutstein, G. E. Morley, H. Tamaddon, D. Vaidya, M. D. Schneider, J. Chen, K. R. Chien, H. Stuhlmann, and G. I. Fishman Conduction Slowing and Sudden Arrhythmic Death in Mice With Cardiac-Restricted Inactivation of Connexin43 Circ. Res., February 16, 2001; 88(3): 333 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Modesti, S. Vanni, I. Bertolozzi, I. Cecioni, G. Polidori, R. Paniccia, B. Bandinelli, A. Perna, P. Liguori, M. Boddi, et al. Early sequence of cardiac adaptations and growth factor formation in pressure- and volume-overload hypertrophy Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H976 - H985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fazio, A. Cittadini, B. Biondi, E. A. Palmieri, G. Riccio, F. Bonè, U. Oliviero, and L. Saccà Cardiovascular Effects of Short-Term Growth Hormone Hypersecretion J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 179 - 182. [Abstract] [Full Text]
|
|
|
|
|
|
I. I. Joffe, K. E. Travers, C. L. Perreault-Micale, T. Hampton, S. E. Katz, J. P. Morgan, and P. S. Douglas Abnormal cardiac function in the streptozotocin-induced, non-insulin-dependent diabetic rat: Noninvasive assessment with Doppler echocardiography and contribution of the nitric oxide pathway J. Am. Coll. Cardiol., December 1, 1999; 34(7): 2111 - 2119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ren, L. Jefferson, J. R. Sowers, and R. A. Brown Influence of Age on Contractile Response to Insulin-Like Growth Factor 1 in Ventricular Myocytes From Spontaneously Hypertensive Rats Hypertension, December 1, 1999; 34(6): 1215 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hugel, M. Reincke, H. Stromer, J. Winning, M. Horn, C. Dienesch, P. Mora, H. H. H. W. Schmidt, B. Allolio, and S. Neubauer Evidence against a role of physiological concentrations of estrogen in post-myocardial infarction remodeling J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1427 - 1434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Brink, J. Chrast, S. R. Price, W. E. Mitch, and P. Delafontaine Angiotensin II Stimulates Gene Expression of Cardiac Insulin-Like Growth Factor I and Its Receptor Through Effects on Blood Pressure and Food Intake Hypertension, November 1, 1999; 34(5): 1053 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-L. Lee, J.-W. Chen, C.-T. Ting, T. Ishiwata, S.-J. Lin, M. Korc, and P. H. Wang Insulin-Like Growth Factor I Improves Cardiovascular Function and Suppresses Apoptosis of Cardiomyocytes in Dilated Cardiomyopathy Endocrinology, October 1, 1999; 140(10): 4831 - 4840. [Abstract] [Full Text]
|
|
|
|
|
|
G. G. N. Serneri, P. A. Modesti, M. Boddi, I. Cecioni, R. Paniccia, M. Coppo, G. Galanti, I. Simonetti, S. Vanni, L. Papa, et al. Cardiac Growth Factors in Human Hypertrophy : Relations With Myocardial Contractility and Wall Stress Circ. Res., July 9, 1999; 85(1): 57 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. ter Maaten, H. de Boer, O. Kamp, L. Stuurman, and E. A. van der Veen Long-Term Effects of Growth Hormone (GH) Replacement in Men with Childhood-Onset GH Deficiency J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2373 - 2380. [Abstract] [Full Text]
|
|
|
|
|
|
T. Meguro, C. Hong, K. Asai, G. Takagi, T. A. McKinsey, E. N. Olson, and S. F. Vatner Cyclosporine Attenuates Pressure-Overload Hypertrophy in Mice While Enhancing Susceptibility to Decompensation and Heart Failure Circ. Res., April 2, 1999; 84(6): 735 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ross Jr Growth Hormone, Cardiomyocyte Contractile Reserve, and Heart Failure Circulation, January 12, 1999; 99(1): 15 - 17. [Full Text] [PDF]
|
|
|
|
|
|
L. H. Young, Y. Renfu, X. Hu, S. Chong, S. Hasan, R. Jacob, and R. S. Sherwin Insulin-like growth factor I stimulates cardiac myosin heavy chain and actin synthesis in the awake rat Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E143 - E150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Grimm, D. Cameron, D. P. Griese, G. A.J. Riegger, and E. P. Kromer Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction Cardiovasc Res, November 1, 1998; 40(2): 297 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ueyama, T. Ohkusa, M. Yano, and M. Matsuzaki Growth hormone preserves cardiac sarcoplasmic reticulum Ca2+ release channels (ryanodine receptors) and enhances cardiac function in cardiomyopathic hamsters Cardiovasc Res, October 1, 1998; 40(1): 64 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, W. Ma, R. Markovich, J.-W. Chen, and P. H. Wang Regulation of Cardiomyocyte Apoptotic Signaling by Insulin-like Growth Factor I Circ. Res., September 7, 1998; 83(5): 516 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Y. Donath, G. Sütsch, X.-W. Yan, B. Piva, H.-P. Brunner, Y. Glatz, J. Zapf, F. Follath, E. R. Froesch, and W. Kiowski Acute Cardiovascular Effects of Insulin-Like Growth Factor I in Patients with Chronic Heart Failure J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3177 - 3183. [Abstract] [Full Text]
|
|
|
|
|
|
J. Ren, M. F. Walsh, M. Hamaty, J. R. Sowers, and R. A. Brown Altered inotropic response to IGF-I in diabetic rat heart: influence of intracellular Ca2+ and NO Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H823 - H830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Tanaka, T. Ryoke, M. Hongo, L. Mao, H. A. Rockman, R. G. Clark, and J. Ross Jr. Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H393 - H399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cittadini, Y. Ishiguro, H. Stromer, M. Spindler, A. C. Moses, R. Clark, P. S. Douglas, J. S. Ingwall, and J. P. Morgan Insulin-like Growth Factor-1 but Not Growth Hormone Augments Mammalian Myocardial Contractility by Sensitizing the Myofilament to Ca2+ Through a Wortmannin-Sensitive Pathway : Studies in Rat and Ferret Isolated Muscles Circ. Res., June 13, 1998; 83(1): 50 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Redaelli, A. Malhotra, B. Li, P. Li, E. H. Sonnenblick, P. A. Hofmann, and P. Anversa Effects of Constitutive Overexpression of Insulin-Like Growth Factor-1 on the Mechanical Characteristics and Molecular Properties of Ventricular Myocytes Circ. Res., March 23, 1998; 82(5): 594 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Ratnakar, C. Sundaram, A. Rajasekhar, K. Gayathri, A. K Prayag, S. Jaishankar, and B. S. Raju Catecholamine Cardiomyopathy: An Autopsy Study Asian Cardiovasc Thorac Ann, March 1, 1998; 6(1): 41 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, W. Ma, R. Markovich, W.-L. Lee, and P. H. Wang Insulin-Like Growth Factor I Modulates Induction of Apoptotic Signaling in H9C2 Cardiac Muscle Cells Endocrinology, March 1, 1998; 139(3): 1354 - 1360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cittadini, H. Stromer, D. E. Vatner, J. D. Grossman, S. E. Katz, R. Clark, J. P. Morgan, and P. S. Douglas Consequences of Growth Hormone Deficiency on Cardiac Structure, Function, and {beta}-Adrenergic Pathway: Studies in Mutant Dwarf Rats Endocrinology, December 1, 1997; 138(12): 5161 - 5169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Sacca Growth hormone: a newcomer in cardiovascular medicine Cardiovasc Res, October 1, 1997; 36(1): 3 - 9. [Full Text] [PDF]
|
|
|
|
|
|
R. Foncea, M. Andersson, A. Ketterman, V. Blakesley, M. Sapag-Hagar, P. H. Sugden, D. LeRoith, and S. Lavandero Insulin-like Growth Factor-I Rapidly Activates Multiple Signal Transduction Pathways in Cultured Rat Cardiac Myocytes J. Biol. Chem., August 1, 1997; 272(31): 19115 - 19124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wickman, P. Friberg, M. A. Adams, G. L. Matejka, C. Brantsing, G. Guron, and J. Isgaard Induction of Growth Hormone Receptor and Insulin-Like Growth Factor-I mRNA in Aorta and Caval Vein During Hemodynamic Challenge Hypertension, January 1, 1997; 29(1): 123 - 130. [Abstract] [Full Text]
|
|
|
|
|
|
H. Stromer, A. Cittadini, P. S. Douglas, and J. P. Morgan Exogenously Administered Growth Hormone and Insulin-like Growth Factor-I Alter Intracellular Ca2+ Handling and Enhance Cardiac Performance: In Vitro Evaluation in the Isolated Isovolumic Buffer-Perfused Rat Heart Circ. Res., August 1, 1996; 79(2): 227 - 236. [Abstract] [Full Text]
|
|
|
|
|
|
C. Lu, G. Schwartzbauer, M. A. Sperling, S. U. Devaskar, S. Thamotharan, P. D. Robbins, C. F. McTiernan, J.-L. Liu, J. Jiang, S. J. Frank, et al. Demonstration of Direct Effects of Growth Hormone on Neonatal Cardiomyocytes J. Biol. Chem., June 15, 2001; 276(25): 22892 - 22900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Palmieri, G. Benincasa, F. Di Rella, C. Casaburi, M. G. Monti, G. De Simone, L. Chiariotti, L. Palombini, C. B. Bruni, L. Sacca, et al. Differential expression of TNF-alpha , IL-6, and IGF-1 by graded mechanical stress in normal rat myocardium Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H926 - H934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Welch, D. Plank, S. Witt, B. Glascock, E. Schaefer, S. Chimenti, A. M. Andreoli, F. Limana, A. Leri, J. Kajstura, et al. Cardiac-Specific IGF-1 Expression Attenuates Dilated Cardiomyopathy in Tropomodulin-Overexpressing Transgenic Mice Circ. Res., April 5, 2002; 90(6): 641 - 648. [Abstract] [Full Text] [PDF]
|
|